Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC, accounting for 90% of primary liver cancer) was the sixth most common cancer in the world and the third leading cause of cancer death in 2020. The number of new HCC patients in China accounted for nearly half of that in the world. HCC was of occult and complex onset, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Lai, Wang, Zeyu, Jing, Niancai, Lu, Yi, Yang, Jili, Xiao, Hongyu, Guo, Huanyu, Sun, Shoukun, Li, Mingjing, Zhao, Daqing, Li, Xiangyan, Qi, Wenxiu, Zhang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338659/
https://www.ncbi.nlm.nih.gov/pubmed/35907976
http://dx.doi.org/10.1186/s13020-022-00645-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338659/
https://www.ncbi.nlm.nih.gov/pubmed/35907976
http://dx.doi.org/10.1186/s13020-022-00645-0

Ejemplares similares